However, FHL2 is frequently downregulated in hepatocellular carcinoma (HCC) and engages with Smad2-4 to regulate gene expression, ultimately inhibiting HCC cell proliferation (11). This evidence concerns the gene SMAD2 and hepatocellular carcinoma.